These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7241794)

  • 1. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phlebitis associated with the intravenous use of cephalothin and cephapirin.
    Sorrentino AP; Haughey EJ; Cronin DW; Bohen LN
    Am J Hosp Pharm; 1976 Jul; 33(7):642-4. PubMed ID: 941915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of side effects of intravenous cephapirin and cephalothin with special reference to the incidence of phlebitis].
    Watanabe A; Oizumi K; Konno K
    Jpn J Antibiot; 1983 Dec; 36(12):3395-8. PubMed ID: 6674550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole.
    Berger S; Ernst EC; Barza M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):575-9. PubMed ID: 5053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of thrombophlebitis associated with three cephalosporin antibiotics.
    Siebert WT; Westerman EL; Smilack JD; Bradshaw MW; Williams TW
    Antimicrob Agents Chemother; 1976 Sep; 10(3):467-9. PubMed ID: 791101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use, misuse, and cost of parenteral cephalosporins at a county hospital.
    Appleby DH; John JF
    South Med J; 1980 Nov; 73(11):1473-5. PubMed ID: 7444511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of phlebitis produced by cephapirin and cephalothin.
    Cross AS; Tramont EC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):722-4. PubMed ID: 1267443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of phlebitis associated with cefazolin and cephalothin.
    Cole DR
    Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):75-7. PubMed ID: 789268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetic studies of cephapirin and cephalothin following intravenous and intramuscular administration.
    Lane AZ; Chudzik GM; Siskin SB
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):117-27. PubMed ID: 401706
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind controlled comparison of phlebitis produced by cephapirin and cephalothin.
    Carrizosa J; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1973 Feb; 3(2):306-7. PubMed ID: 4597719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics of cefamandole, cephapirin, and cephalothin in healthy subjects and effect of repeated dosing.
    Barza M; Melethil S; Berger S; Ernst EC
    Antimicrob Agents Chemother; 1976 Sep; 10(3):421-5. PubMed ID: 984783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind study to investigate methods to prevent cephalothin-induced phlebitis.
    Maddox RR; Rush DR; Rapp RP; Foster TS; Mazella V; McKean HE
    Am J Hosp Pharm; 1977 Jan; 34(1):29-34. PubMed ID: 831472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in combination therapy with amikacin and cephapirin for infections complicated with acute leukemia during induction chemotherapy].
    Hasegawa S; Nakao I
    Jpn J Antibiot; 1984 Sep; 37(9):1631-6. PubMed ID: 6512982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin.
    Feld R; Tuffnell PG; Curtis JE; Messner HA; Hasselback R
    Arch Intern Med; 1979 Mar; 139(3):310-4. PubMed ID: 426575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of absorption and excretion of cefazolin with cephalothin and cephapirin.
    Shimizu T
    Jpn J Antibiot; 1975 Aug; 28(4):542-8. PubMed ID: 1160145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation.
    Green ER; Subramanian S; Faden H; Quintiliani R; Nightingale CH
    Ann Thorac Surg; 1981 Feb; 31(2):155-60. PubMed ID: 7458486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and in vitro evaluation of cephapirin, a new cephalosporin antibiotic.
    Bran JL; Levison ME; Kaye D
    Antimicrob Agents Chemother; 1972 Jan; 1(1):35-40. PubMed ID: 4596741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocytopenia in hospitalized patients. II. A prospective comparison of two antibiotic regimens in the empiric therapy of febrile patients.
    Gurwith M; Brunton JL; Lank B; Ronald AR; Harding GK; McCullough DW
    Am J Med; 1978 Jan; 64(1):127-32. PubMed ID: 623129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.